Immunai
Peripheral Tissue Analysis
Active
B
Startup
Tel Aviv-Yafo
Founded 2019-01
Immunai is developing a proprietary data set of multi-omic, immune-centric peripheral tissue analyses. The company's advanced analytics and data-visualization interface allows researchers to comprehensively view and interrogate data and to derive novel conclusions on the underlying mechanisms of disease. The platform is currently being used to develop and r…
SectorHealth Tech & Life Sciences
StageB
Total raised$295.0M
Employees192
Founded2019-01
HQTel Aviv-Yafo
Crunchbaseimmunai
Confidence91
Sectors
Business SoftwareIT, R&D & Data SolutionsData Analysis & Decision SupportHealth Tech & Life SciencesDigital HealthcareMedical Decision Support
Technology
Artificial IntelligenceDeep LearningMachine Learning
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticals